Patrizia Murino

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

Emanuele Durante‐Mangoni, Giuseppe Signoriello, Roberto Andini et al. · Clinical Infectious Diseases · 2013 · 407 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar et al. · Clinical Infectious Diseases · 2018 · 126 citations

Life Sciences, Infectious Diseases, Microbiology +17

Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS

Michele D’Alto, Alberto M. Marra, Sergio Severino et al. · Critical Care · 2020 · 119 citations · Full text

Medicine, Cardiology, Infectious Diseases +17

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Vincenzo Montesarchio, Roberto Parella, Chiara Iommelli et al. · Journal for ImmunoTherapy of Cancer · 2020 · 90 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Amir Nutman, Jonathan Lellouche, Elizabeth Temkin et al. · Clinical Microbiology and Infection · 2020 · 78 citations

Life Sciences, Infectious Diseases, Pharmacology +16